Surgery
Volume 28, Issue 5 , Pages 198-204 , May 2010

Pancreatic cancer

References 

  1. Cancer Research UK. Pancreatic cancer. http://info.cancerresearchuk.org/cancerstats/types/pancreas/.
  2. Vrieling A, Bueno-de-Mesquita HB, Boshuizen HC, et al. Cigarette smoking, environmental tobacco smoke exposure and pancreatic cancer risk in the European prospective investigation into cancer and nutrition. Int J Cancer 2009, doi:10.1002/ijc.24907, [epub ahead of print].
  3. Tramacere I, Scotti L, Jenab M, et al. Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose–risk relation.. Int J Cancer. 2010;126:1474–1486
  4. Brugge WR, Lauwers GY, Sahani D, Fernandez-del Castillo C, Warshaw AL. Cystic neoplasms of the pancreas. N Engl J Med. 2004;351:1218–1226
  5. Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004;239:788–797
  6. Pancreatic Section , British Society of Gastroenterology , Pancreatic Society of Great Britain and Ireland , Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland , Royal College of Pathologists , Special Interest Group for Gastro-Intestinal Radiology . Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut. 2005;54:v1–v16
  7. Takhar AS, Palaniappan P, Dhingsa R, Lobo DN. Recent developments in diagnosis of pancreatic cancer. BMJ. 2004;329:668–673
  8. Ghaneh P, Neoptolemos JP. Pancreatic exocrine tumours. In:  Weinstein WM,  Hawkey CJ,  Bosch J editor. Clinical gastroenterology and hepatology. London: Elsevier; 2005;p. 521–533
  9. Sewnath ME, Karsten TM, Prins MH, Rauws EJ, Obertop H, Gouma DJ. A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg. 2002;236:17–27
  10. Pisters PW, Lee JE, Vauthey JN, Charnsangavej C, Evans DB. Laparoscopy in the staging of pancreatic cancer. Br J Surg. 2001;88:325–337
  11. Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350:1200–1210
  12. Keedy VL, Berlin J. Adjuvant and neoadjuvant approaches to treat surgically resectable pancreatic cancer. Curr Treat Options Oncol. 2006;7:381–388
  13. Neoptolemos J, Buchler M, Stocken DD, et al. A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma. J Clin Oncol. 2009;27:Abstract LBA505
  14. Golcher H, Brunner T, Grabenbauer G, et al. Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy. Eur J Surg Oncol. 2008;34:756–764
  15. Turrini O, Viret F, Moureau-Zabotto L, et al. Neoadjuvant 5 fluorouracil–cisplatin chemoradiation effect on survival in patients with resectable pancreatic head adenocarcinoma: a ten-year single institution experience. Oncology. 2009;76:413–419
  16. Yip D, Karapetis C, Strickland A, Steer CB, Goldstein D. Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer. Cochrane Database Syst Rev. 2006;3::CD002093
  17. Cardenes HR, Chiorean EG, Dewitt J, Schmidt M, Loehrer P. Locally advanced pancreatic cancer: current therapeutic approach. Oncologist. 2006;11:612–623
  18. Hadjicostas P, Malakounides N, Varianos C, Kitiris E, Lerni F, Symeonides P. Radiofrequency ablation in pancreatic cancer. HPB. 2006;8:61–64
  19. Fischer L, Kleeff J, Esposito I, et al. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours if the pancreas. Br J Surg. 2008;95:627–635

PII: S0263-9319(10)00016-5

doi: 10.1016/j.mpsur.2010.01.005

Surgery
Volume 28, Issue 5 , Pages 198-204 , May 2010